Their results revealed the down-regulation of PER1, PER2, BMAL1, and Wee1 genes and the up-regulation of Cyclin D1 and Myc genes in CLL patients, compared with healthy controls. The gene discussed is MYC; the disease is B-cell chronic lymphocytic leukemia.